VITAROS 330 MCG / 100 MG
ALPROSTADIL : 330 MCG / 100 MG · DIN 02359421 · BGP PHARMA ULC
Health Canada status: APPROVED
What is VITAROS?
VITAROS 330 MCG / 100 MG contains ALPROSTADIL : 330 MCG / 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02359421, held by BGP PHARMA ULC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as approved, status dated 22-Jan-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is VITAROS used for?
Treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02359421 |
|---|---|
| Brand name | VITAROS |
| Generic / active ingredient | ALPROSTADIL : 330 MCG / 100 MG |
| Manufacturer | BGP PHARMA ULC |
| Strength | 330 MCG / 100 MG |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | G04BE01 ALPROSTADIL |
| AHFS class | 24:12.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 22-Jan-2015 |
How is it administered?
Apply to the tip of the penis (meatus) 5-30 mins before intercourse. Max frequency: once per 24-hour period. Initial dose usually 220 mcg. Single-use dispenser.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
null
How is it supplied?
null
Contraindications
Hypersensitivity; conditions predisposing to priapism; penile abnormalities; unstable cardiovascular disease; use with pregnant/lactating partners or for oral sex without a condom.
Warnings and precautions
Seek medical help for erections >4 hours (priapism). Risk of hypotension/syncope; avoid hazardous tasks like driving after use. Potential for transfer to partner.
What can be used instead?
Other Canadian products sharing ATC code G04BE01 ALPROSTADIL. 2 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CAVERJECT STERILE POWDER | 20 MCG | LIQUID ; KIT ; POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02215756 |
| CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL | 20 MCG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02215187 |
| CAVERJECT STERILE POWDER - KIT 11.9MCG /VIAL | 99.1 % | POWDER FOR SOLUTION ; KIT ; LIQUID | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02215748 |
| CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL | 11.9 MCG | POWDER FOR SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02215179 |
| MUSE | 1000 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238595 |
| MUSE | 125 MCG | SUPPOSITORY | PALADIN PHARMA INC. | CANCELLED PRE MARKET | DIN 02238592 |
| MUSE | 250 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238593 |
| MUSE | 500 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238594 |
| VITAROS | 220 MCG / 100 MG | CREAM | BGP PHARMA ULC | APPROVED | DIN 02359413 |
Who else supplies ALPROSTADIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ALPROSTADIL appears in 39 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.